ArticleCell cycle (Georgetown, Tex.)2017

Salmonella typhimurium A1-R targeting of a chemotherapy-resistant BRAF-V600E melanoma in a patient-derived orthotopic xenograft (PDOX) model is enhanced in combination with either vemurafenib or temozolomide.

Kei Kawaguchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.